Systematic expansion of the clinical evidence base in opioid prescribing for refractory dyspnoea at the end of life

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/480459

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Morphine can relieve breathlessness in the palliative setting. But many important questions remain. What is the best dose, should the dose change over time, do different medications provide the same relief, and how common is dyspnoea in the general population? This three part project will extend our knowledge to answer these questions. Population data will provide critical background to plan best care for future palliative patients distressed by breathlessness.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $414,535.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Controlled clinical trial | End-of-life care | End-stage cardiac disease | End-stage respiratory disease | Health services planning | Opioids | Palliative Care | Population symptom prevalence survey | Refractory dyspnoea | Symptom control

Related Links